A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomy.

Zhe CaoJiangdong QiuJunchao GuoGuangbing XiongKuirong JiangShangyou ZhengTiantao KuangYongwei WangTaiping ZhangBei SunRenyi QinRufu ChenYi MiaoWenhui LouYupei Zhao

Published in: Journal of gastroenterology (2021)

NCT03349424.

Keyphrases

clinical trial
study protocol
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
open label
patients undergoing
peritoneal dialysis
randomized controlled trial
phase iii